Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

[Ectopic tissue of the female genital tract].

Otterbach F, Schmidt D.

Pathologe. 2018 Sep;39(5):424-430. doi: 10.1007/s00292-018-0477-z. Review. German.

PMID:
30155695
2.

ERCC1-positive circulating tumor cells in the blood of ovarian cancer patients as a predictive biomarker for platinum resistance.

Kuhlmann JD, Wimberger P, Bankfalvi A, Keller T, Schöler S, Aktas B, Buderath P, Hauch S, Otterbach F, Kimmig R, Kasimir-Bauer S.

Clin Chem. 2014 Oct;60(10):1282-9. doi: 10.1373/clinchem.2014.224808. Epub 2014 Jul 11.

3.

Neoadjuvant, anthracycline-free chemotherapy with carboplatin and docetaxel in triple-negative, early-stage breast cancer: a multicentric analysis of feasibility and rates of pathologic complete response.

Kern P, Kalisch A, Kolberg HC, Kimmig R, Otterbach F, von Minckwitz G, Sikov WM, Pott D, Kurbacher C.

Chemotherapy. 2013;59(5):387-94. doi: 10.1159/000362756. Epub 2014 May 13.

4.

Comparison of the diagnostic value of FDG-PET/CT and axillary ultrasound for the detection of lymph node metastases in breast cancer patients.

Riegger C, Koeninger A, Hartung V, Otterbach F, Kimmig R, Forsting M, Bockisch A, Antoch G, Heusner TA.

Acta Radiol. 2012 Dec 1;53(10):1092-8. doi: 10.1258/ar.2012.110635. Epub 2012 Sep 22.

PMID:
23002144
5.

New insight into the SDF-1/CXCR4 axis in a breast carcinoma model: hypoxia-induced endothelial SDF-1 and tumor cell CXCR4 are required for tumor cell intravasation.

Jin F, Brockmeier U, Otterbach F, Metzen E.

Mol Cancer Res. 2012 Aug;10(8):1021-31. doi: 10.1158/1541-7786.MCR-11-0498. Epub 2012 Jul 5.

6.

FDG-PET/CT for the early prediction of histopathological complete response to neoadjuvant chemotherapy in breast cancer patients: initial results.

Buchbender C, Kuemmel S, Hoffmann O, Stahl AR, Kimmig R, Otterbach F, Ladd S, Koeninger A, Forsting M, Bockisch A, Antoch G, Heusner TA.

Acta Radiol. 2012 Jul;53(6):628-36. doi: 10.1258/ar.2012.110699. Epub 2012 Jul 3.

PMID:
22761341
7.

Whole-body FDG PET/CT is more accurate than conventional imaging for staging primary breast cancer patients.

Riegger C, Herrmann J, Nagarajah J, Hecktor J, Kuemmel S, Otterbach F, Hahn S, Bockisch A, Lauenstein T, Antoch G, Heusner TA.

Eur J Nucl Med Mol Imaging. 2012 May;39(5):852-63. doi: 10.1007/s00259-012-2077-0. Epub 2012 Mar 6.

PMID:
22392069
8.

Loss of heterozygosity proximal to the M6P/IGF2R locus is predictive for the presence of disseminated tumor cells in the bone marrow of ovarian cancer patients before and after chemotherapy.

Kuhlmann JD, Schwarzenbach H, Otterbach F, Heubner M, Wimberger P, Worm KH, Kimmig R, Kasimir-Bauer S.

Genes Chromosomes Cancer. 2011 Aug;50(8):598-605. doi: 10.1002/gcc.20882. Epub 2011 May 11.

PMID:
21563231
9.

Intraocular biopsy using special forceps: a new instrument and refined surgical technique.

Akgul H, Otterbach F, Bornfeld N, Jurklies B.

Br J Ophthalmol. 2011 Jan;95(1):79-82. doi: 10.1136/bjo.2008.148395.

PMID:
21163820
10.

Diagnostic accuracy of fused positron emission tomography/magnetic resonance mammography: initial results.

Heusner TA, Hahn S, Jonkmanns C, Kuemmel S, Otterbach F, Hamami ME, Stahl AR, Bockisch A, Forsting M, Antoch G.

Br J Radiol. 2011 Feb;84(998):126-35. doi: 10.1259/bjr/93330765. Epub 2010 Oct 19.

11.

The XbaI G>T polymorphism of the glucose transporter 1 gene modulates 18F-FDG uptake and tumor aggressiveness in breast cancer.

Grabellus F, Sheu SY, Bachmann HS, Lehmann N, Otterbach F, Heusner TA, Antoch G, Bockisch A, Kimmig R, Schmid KW, Stahl AR.

J Nucl Med. 2010 Aug;51(8):1191-7. doi: 10.2967/jnumed.110.075721.

12.

The CYP1A1 Ile462Val polymorphism and platinum resistance of epithelial ovarian neoplasms.

Heubner M, Wimberger P, Riemann K, Kasimir-Bauer S, Otterbach F, Kimmig R, Siffert W.

Oncol Res. 2010;18(7):343-7.

PMID:
20377136
13.

[Ocular masquerade syndrome due to sarcoidosis].

Biewald E, Bornfeld N, Otterbach F, Metz K.

Klin Monbl Augenheilkd. 2010 Mar;227(3):226-7. doi: 10.1055/s-0029-1245121. Epub 2010 Mar 16. German. No abstract available.

PMID:
20234988
14.

[Intraocular medulloepithelioma - series of 10 cases and review of the literature].

Holdt M, Jurklies C, Schueler A, Otterbach F, Bornfeld N.

Klin Monbl Augenheilkd. 2009 Dec;226(12):1017-22. doi: 10.1055/s-0028-1109944. Epub 2009 Dec 15. Review. German.

PMID:
20108196
15.

Association of the AA genotype of the BCL2 (-938C>A) promoter polymorphism with better survival in ovarian cancer.

Heubner M, Wimberger P, Otterbach F, Kasimir-Bauer S, Siffert W, Kimmig R, Nückel H.

Int J Biol Markers. 2009 Oct-Dec;24(4):223-9.

PMID:
20082279
16.

Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer.

Schwarzenbach H, Pantel K, Kemper B, Beeger C, Otterbach F, Kimmig R, Kasimir-Bauer S.

Breast Cancer Res. 2009;11(5):R71. doi: 10.1186/bcr2404.

17.

The AA genotype of a L1C G842A polymorphism is associated with an increased risk for ovarian cancer.

Heubner M, Wimberger P, Kasimir-Bauer S, Otterbach F, Kimmig R, Siffert W.

Anticancer Res. 2009 Aug;29(8):3449-52.

18.

Prognostic relevance of the AQP5 -1364C>A polymorphism in primary breast cancer.

Kasimir-Bauer S, Heubner M, Otterbach F, Kimmig R, Siffert W, Adamzik M.

Mol Med Rep. 2009 Jul-Aug;2(4):645-50. doi: 10.3892/mmr_00000151.

PMID:
21475880
19.

Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients.

Heusner TA, Kuemmel S, Hahn S, Koeninger A, Otterbach F, Hamami ME, Kimmig KR, Forsting M, Bockisch A, Antoch G, Stahl A.

Eur J Nucl Med Mol Imaging. 2009 Oct;36(10):1543-50. doi: 10.1007/s00259-009-1145-6. Epub 2009 May 5.

PMID:
19415270
20.

Aquaporin 1 (AQP1) expression is a novel characteristic feature of a particularly aggressive subgroup of basal-like breast carcinomas.

Otterbach F, Callies R, Adamzik M, Kimmig R, Siffert W, Schmid KW, Bankfalvi A.

Breast Cancer Res Treat. 2010 Feb;120(1):67-76. doi: 10.1007/s10549-009-0370-9. Epub 2009 Mar 21.

PMID:
19306058
21.

The haplotype of two FSHR polymorphisms in ovarian cancer--a potential role of ethnology in risk modification.

Heubner M, Riemann K, Otterbach F, Kimmig R, Kasimir-Bauer S, Siffert W, Wimberger P.

Gynecol Oncol. 2009 Mar;112(3):486-9. doi: 10.1016/j.ygyno.2008.12.011. Epub 2009 Jan 15.

PMID:
19147210
22.

[Aquaporin 1 expression in invasive breast carcinomas].

Otterbach F, Callies R, Kimmig R, Schmid KW, Bánkfalvi A.

Pathologe. 2008 Nov;29 Suppl 2:357-62. doi: 10.1007/s00292-008-1039-6. German.

PMID:
18841368
23.

The AA genotype of the regulatory BCL2 promoter polymorphism ( 938C>A) is associated with a favorable outcome in lymph node negative invasive breast cancer patients.

Bachmann HS, Otterbach F, Callies R, Nückel H, Bau M, Schmid KW, Siffert W, Kimmig R.

Clin Cancer Res. 2007 Oct 1;13(19):5790-7.

24.

Influence of platinum-based chemotherapy on disseminated tumor cells in blood and bone marrow of patients with ovarian cancer.

Wimberger P, Heubner M, Otterbach F, Fehm T, Kimmig R, Kasimir-Bauer S.

Gynecol Oncol. 2007 Nov;107(2):331-8. Epub 2007 Aug 31.

PMID:
17764727
25.

MR-guided vacuum-assisted breast biopsy with a handheld biopsy system: clinical experience and results in postinterventional MR mammography after 24 h.

Hauth EA, Jaeger HJ, Lubnau J, Maderwald S, Otterbach F, Kimmig R, Forsting M.

Eur Radiol. 2008 Jan;18(1):168-76. Epub 2007 Jul 3.

PMID:
17609959
26.

The T393C polymorphism in the gene GNAS1 of G protein is associated with survival of patients with invasive breast carcinoma.

Otterbach F, Callies R, Frey UH, Schmitz KJ, Wreczycki C, Kimmig R, Siffert W, Schmid KW.

Breast Cancer Res Treat. 2007 Nov;105(3):311-7. Epub 2006 Dec 21.

PMID:
17186357
27.

[Salivary gland-like tumors of the breast].

Otterbach F, Schmid KW.

Pathologe. 2006 Sep;27(5):363-72. German.

PMID:
16896677
28.

[Bone damaging swelling of the side of the nose].

Oztürk E, Otterbach F, Werner M, Neumann A.

HNO. 2006 Dec;54(12):958-61. German. No abstract available.

PMID:
16823571
29.
30.

Prognostic value of c-erbB-2 expression in papillary thyroid carcinoma.

Freudenberg LS, Sheu S, Görges R, Mann K, Bokler S, Frilling A, Schmid KW, Bockisch A, Otterbach F.

Nuklearmedizin. 2005;44(5):179-82, 184.

PMID:
16395492
31.

[MR-guided vacuum assisted breast biopsy].

Hauth EA, Reiter K, Hoffmann O, Otterbach F, Kimmig R, Forsting M.

Zentralbl Gynakol. 2005 Dec;127(6):400-6. German.

PMID:
16341985
32.

Relationship and prognostic significance of phospho-(serine 166)-murine double minute 2 and Akt activation in node-negative breast cancer with regard to p53 expression.

Schmitz KJ, Grabellus F, Callies R, Wohlschlaeger J, Otterbach F, Kimmig R, Levkau B, Schmid KW, Baba HA.

Virchows Arch. 2006 Jan;448(1):16-23. Epub 2005 Oct 6.

PMID:
16208531
33.

High expression of focal adhesion kinase (p125FAK) in node-negative breast cancer is related to overexpression of HER-2/neu and activated Akt kinase but does not predict outcome.

Schmitz KJ, Grabellus F, Callies R, Otterbach F, Wohlschlaeger J, Levkau B, Kimmig R, Schmid KW, Baba HA.

Breast Cancer Res. 2005;7(2):R194-203. Epub 2005 Jan 7.

34.

ETV6-NTRK3 gene fusion in a secretory carcinoma of the breast of a male-to-female transsexual.

Grabellus F, Worm K, Willruth A, Schmitz KJ, Otterbach F, Baba HA, Kimmig R, Metz KA.

Breast. 2005 Feb;14(1):71-4.

PMID:
15695086
35.

Erdheim-Chester disease: case report with multisystemic manifestations including testes, thyroid, and lymph nodes, and a review of literature.

Sheu SY, Wenzel RR, Kersting C, Merten R, Otterbach F, Schmid KW.

J Clin Pathol. 2004 Nov;57(11):1225-8. Review.

36.

Heat shock protein 72 and apoptosis indicate cardiac decompensation during early multiple organ failure in sheep.

Baba HA, Wohlschlaeger J, Stubbe HD, Grabellus F, Aken HV, Schmitz KJ, Otterbach F, Schmid KW, August C, Levkau B, Hinder F.

Intensive Care Med. 2004 Jul;30(7):1405-13. Epub 2004 Feb 24.

PMID:
14985962
37.

Prognostic relevance of activated Akt kinase in node-negative breast cancer: a clinicopathological study of 99 cases.

Schmitz KJ, Otterbach F, Callies R, Levkau B, Hölscher M, Hoffmann O, Grabellus F, Kimmig R, Schmid KW, Baba HA.

Mod Pathol. 2004 Jan;17(1):15-21.

38.

Rare expression of target antigens for immunotherapy on disseminated tumor cells in breast cancer patients without overt metastases.

Kasimir-Bauer S, Otterbach F, Oberhoff C, Schmid KW, Kimmig R, Seeber S.

Int J Mol Med. 2003 Dec;12(6):969-75.

PMID:
14612976
39.

[Hyperplasia and tumors of the parathyroid glands].

Sheu SY, Otterbach F, Frilling A, Schmid KW.

Pathologe. 2003 Sep;24(5):373-81. Epub 2003 Jun 19. Review. German.

PMID:
12961025
40.

31-year-old injection drug user with massive skin necrosis and shock.

Hengge UR, Beiderlinden M, Otterbach F, Groeben H, Nast-Kolb D, Mehnert WH, Peters J, Schmid KW.

Dermatology. 2003;206(2):169-71.

PMID:
12592088
41.

[Purpura fulminans. A fatal consequence of a widely used medication?].

Hengge UR, Jochum C, Tschakarjan E, Maschke J, Erbel R, Schmid KW, Otterbach F.

Hautarzt. 2002 Jul;53(7):483-7. German.

PMID:
12219272
42.

Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast.

Otterbach F, Bànkfalvi A, Bergner S, Decker T, Krech R, Boecker W.

Histopathology. 2000 Sep;37(3):232-40.

PMID:
10971699
43.

Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes.

Buerger H, Otterbach F, Simon R, Schäfer KL, Poremba C, Diallo R, Brinkschmidt C, Dockhorn-Dworniczak B, Boecker W.

J Pathol. 1999 Dec;189(4):521-6.

PMID:
10629552
44.

Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways.

Buerger H, Otterbach F, Simon R, Poremba C, Diallo R, Decker T, Riethdorf L, Brinkschmidt C, Dockhorn-Dworniczak B, Boecker W.

J Pathol. 1999 Mar;187(4):396-402.

PMID:
10398097
45.

Telomerase activity in human proliferative breast lesions.

Poremba C, Böcker W, Willenbring H, Schäfer KL, Otterbach F, Bürger H, Diallo R, Dockhorn-Dworniczak B.

Int J Oncol. 1998 Mar;12(3):641-8.

PMID:
9472105
46.

Plasma-induced surface modifications on silicone intraocular lenses: chemical analysis and in vitro characterization.

Hettlich HJ, Otterbach F, Mittermayer C, Kaufmann R, Klee D.

Biomaterials. 1991 Jul;12(5):521-4.

PMID:
1892989

Supplemental Content

Loading ...
Support Center